| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-916
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2800-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0387
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2227-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0325
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-0271
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-0276
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8509 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85 |
| filingDate |
2002-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8b5401046b7b5feb3f292685b67370e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2dff2e856cdfd90babf8190acaa3de6 |
| publicationDate |
2002-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2002165192-A1 |
| titleOfInvention |
Control of NK cell function and survival by modulation of ship activity |
| abstract |
Inhibition of dendritic cell function in solid organ grafts or allogeneic bone marrow transplants prior to or during engraftment by blocking SH2-containing inositol phosphatase (SHIP) expression or function is taught as a method of abrogating immune rejection and thereby increasing the efficacy of engraftment of an allogeneic bone marrow transplant or solid organ allograft or xenograft. Also disclosed is a transgenic mouse having the genotype SHIP −/− which exhibits enhanced survival following mismatched allogeneic marrow grafts. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8008273-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10407729-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8163710-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002137711-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9057109-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010099737-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7807646-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010260730-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7691821-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011064704-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007224124-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11753687-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010144841-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2428563-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11332795-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011052546-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11578373-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7763592-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010136026-A1 |
| priorityDate |
2000-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |